FdaApplication

ANDA 206222

Back to search

Identifiers

Properties

PropertyValue
applicant_nameIPCA LABORATORIES LTD
application_typeANDA
approval_date2023-12-29

Products (3)

ProductActive ingredientStrengthDosage form
ESZOPICLONEESZOPICLONE1MGTABLET;ORAL
ESZOPICLONEESZOPICLONE2MGTABLET;ORAL
ESZOPICLONEESZOPICLONE3MGTABLET;ORAL

3 products